IL6 and metastatic colorectal cancer: According to a large study by Thomsen et al. [137], a high serum level CRP and IL-6 was associated to a severely impaired health-related quality of life compared to patients with normal levels in 512 patients with metastatic colorectal cancer patients receiving first line chemotherapy with or without Cetuximab.